HI
LGND icon

Harbour Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Harbour Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-48
Closed -$4K – 3226
2021
Q3 		$4K Hold
48
– – ﹤0.01% 3078
2021
Q2 		$4K Sell
48
-53
-52% -$4.41K ﹤0.01% 3145
2021
Q1 		$10K Buy
+101
New +$9.55K ﹤0.01% 2613

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Harbour Investments's LGND Position: Q4 2021 in Review

Harbour Investments sold out of Ligand Pharmaceuticals (LGND) in Q4 2021, closing a stake of 48 shares — an estimated $4K sold.

Harbour Investments first reported a position in LGND in Q1 2021 and held it in 3 quarters. The position peaked at $10K in Q1 2021. 221 funds tracked by Wall St. Rank hold LGND as of Q4 2021.

  • Harbour Investments reported no remaining Ligand Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 48 Ligand Pharmaceuticals shares in Q4 2021, an estimated $4K.
  • Harbour Investments first reported a position in Ligand Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Ligand Pharmaceuticals position peaked at $10K in Q1 2021.
  • 221 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.